Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs).
Current drug targets. Infectious disorders·2002
Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogen.
Clinical and experimental immunology·2001
HIV-Specific CD4(+) and CD8(+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2001
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant.
Journal of acquired immune deficiency syndromes (1999)·2000
Revisiting the function of the HSV-1 UL45 protein.
Virology·2026
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026